LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 58.88 | 84.90 | 803 | 7291 | 0.1101 | 0.4187 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 60.59 | 84.90 | 6 | 7641 | 0.0008 | -0.3351 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 60.59 | 84.90 | 696 | 7641 | 0.0911 | 0.3828 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 60.59 | 84.90 | 69 | 7641 | 0.0090 | -0.0314 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 60.59 | 84.90 | 785 | 7641 | 0.1027 | 0.4086 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 62.29 | 84.90 | 1 | 7934 | 0.0001 | -0.4926 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 62.29 | 84.90 | 665 | 7934 | 0.0838 | 0.3695 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 62.29 | 84.90 | 27 | 7934 | 0.0034 | -0.1605 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 62.29 | 84.90 | 784 | 7934 | 0.0988 | 0.4044 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 63.99 | 84.90 | 1 | 8212 | 0.0001 | -0.4900 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 63.99 | 84.90 | 661 | 8212 | 0.0805 | 0.3650 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 63.99 | 84.90 | 24 | 8212 | 0.0029 | -0.1743 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 63.99 | 84.90 | 777 | 8212 | 0.0946 | 0.3989 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 65.70 | 84.90 | 1 | 8484 | 0.0001 | -0.4876 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 65.70 | 84.90 | 627 | 8484 | 0.0739 | 0.3512 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 65.70 | 84.90 | 13 | 8484 | 0.0015 | -0.2461 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 65.70 | 84.90 | 763 | 8484 | 0.0899 | 0.3917 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 67.41 | 84.90 | 1 | 8766 | 0.0001 | -0.4852 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 67.41 | 84.90 | 557 | 8766 | 0.0635 | 0.3247 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 67.41 | 84.90 | 8 | 8766 | 0.0009 | -0.2975 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 67.41 | 84.90 | 751 | 8766 | 0.0857 | 0.3852 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 69.11 | 84.90 | 1 | 8988 | 0.0001 | -0.4833 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 69.11 | 84.90 | 493 | 8988 | 0.0549 | 0.2989 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 69.11 | 84.90 | 8 | 8988 | 0.0009 | -0.2961 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 69.11 | 84.90 | 738 | 8988 | 0.0821 | 0.3792 | MN20160318_Q02 | N03 |